Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EGFR-IN-9 is a potent EGFR kinase inhibitor with IC50s of 7 nM, 28 nM for the wild type EGFR kinase and double mutant EGFR kinase (L858R/T790M). EGFR-IN-9 has antitumor activity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 30,500 | |||
5 mg | 在庫あり | ¥ 75,500 | |||
10 mg | 在庫あり | ¥ 121,500 | |||
25 mg | 在庫あり | ¥ 197,500 | |||
50 mg | 在庫あり | ¥ 273,500 | |||
100 mg | 在庫あり | ¥ 363,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 83,500 |
説明 | EGFR-IN-9 is a potent EGFR kinase inhibitor with IC50s of 7 nM, 28 nM for the wild type EGFR kinase and double mutant EGFR kinase (L858R/T790M). EGFR-IN-9 has antitumor activity. |
ターゲット&IC50 | EGFR (L858R/T790M):28 nM, EGFR (WT):7 nM |
In vitro | EGFR-IN-9 shows antiproliferative activity in HCC827 lung cancer cell line with an IC50 of 8 nM[1]. |
分子量 | 476.53 |
分子式 | C29H24N4O3 |
CAS No. | 1226549-39-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90 mg/mL (188.9 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EGFR-IN-9 1226549-39-8 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR EGFRIN9 EGFR IN 9 Inhibitor inhibitor inhibit